Publications
-
2012 Registration Document -
Registration document 2011 -
The Group in 2011 -
Registration document 2010 -
2010 key figures and strategy project -
Registration Document 2009 -
Annual Report 2009 -
Annual Report 2008 -
Registration Document 2008 -
A convergence of approaches for therapeutic research
Press releases
-
25 April 2013Paris (France)Ipsen expects Increlex® supply interruption due to supplier manufacturing issues
-
25 April 2013Paris (France)Active Biotech and Ipsen update the analysis plan for the 10TASQ10 trial evaluating tasquinimod in the treatment of prostate cancer
-
25 April 2013Paris (France)Ipsen’s first quarter 2013 sales